Pablo G. Longo

Statistics

Publications

Citations

1.2K

H-Index

Active since

2006

Affiliations

International Centre for Genetic Engineering and Biotechnology(Current)

Agostino Gemelli University Polyclinic

Catholic University of America

European Molecular Biology Laboratory

Università Cattolica del Sacro Cuore

Pablo G. Longo is an author at International Centre for Genetic Engineering and Biotechnology specializing in signal transduction, cell signaling, and life sciences.

Publications per year

2006–2014

Publications

The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells

Pablo G. Longo, Luca Laurenti, Stefania Gobessi et al. · Blood · 2007 · 315 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells

Stefania Gobessi, Luca Laurenti, Pablo G. Longo et al. · Leukemia · 2008 · 195 citations

Life Sciences, Cell Biology, Oncology +11

ZAP-70 enhances B-cell–receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells

Stefania Gobessi, Luca Laurenti, Pablo G. Longo et al. · Blood · 2006 · 170 citations

Life Sciences, Cell Biology, Immunology +16

The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the Eμ- TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling

Mirza Suljagić, Pablo G. Longo, Sara Bennardo et al. · Blood · 2010 · 142 citations · Full text

Medicine, Oncology, Pharmacology +17

The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease

Pablo G. Longo, Luca Laurenti, Stefania Gobessi et al. · Leukemia · 2006 · 141 citations

Life Sciences, Cell Biology, Oncology +13

1–5 of 10